Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0262471 (
ENT
)
5,307
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To facilitate the clinical understanding of Wegener's granulomatosis, the morphological changes involved are discussed. Such changes may be found in the entire respiratory tract or may be limited to either the upper or the lower respiratory tract with varying severity. When confronted with the nasopharyngeal course of the disease, the
ENT
specialist should realize that nasal and pulmonary variants can coexist. Classifications such as
Granuloma
gangraenescens, lethal midline granuloma or midline granuloma stress localized processes and fail to associate possible pulmonary involvement or manifestation in other organs. Such descriptions are therefore unsuitable for an understanding of the disease.
...
PMID:[A contribution on the manifestations of wegener's granulomatosis (author's transl)]. 89 50